Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow
Pediatric Cardiology · 2024
DOI: 10.1007/s00246-023-03386-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2024. Verfasst von Srujan Ganta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery, Rady Children's Hospital + University of California San Diego, 3020 Children's Way, MC5004, San Diego, CA, 92123, USA. sganta…. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Univentricular Heart. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patent ductus arteriosus stenting (PDAS) for ductal-dependent pulmonary blood flow (DDPBF) provides a new paradigm for managing neonates with single ventricles (SV). Currently, sparse data exist regarding outcomes for subsequent palliation. We describe our experience with inter-stage care and stage 2 (S2P) conversion with PDAS in comparison to a prior era of patients who received surgical aorto-pulmonary shunts (APS). Retrospective review of 18 consecutive DDPBF SV patients treated with PDAS between 2016 and 2021 was done and compared with 9 who underwent APS from 2010 to 2016. Patient outcomes and pulmonary artery (PA) growth were analyzed. S2P was completed in all 18 with PDAS with no cardiac arrests and one post-S2P mortality. In the 9 APS patients, there was one cardiac arrest requiring ECMO and one mortality inter-stage. Off cardiopulmonary bypass strategy was utilized in 10/18 in the PDAS and 1/9 in the APS group ( p = 0.005) at S2P. Shorter ventilation time, earlier PO feeding, and shorter hospital stay were noted in the PDAS group ( p = 0.01, p = 0.006, p = 0.03) (S2P). Median Nakata index increase inter-stage was not significant between the PDAS and APS at 94.1 mm 2 /m 2 versus 71.7 mm 2 /m 2 ( p = 0.94). Median change in pulmonary artery symmetry (PAS) was − 0.02 and − 0.24, respectively, which was statistically significant ( p = 0.008). Neurodevelopmental outcomes were better in the PDAS group compared to the APS group ( p = 0.02). PDAS provides excellent PA growth, inter-stage survival, progression along multistage single-ventricle palliation, and potentially improved neurodevelopmental outcomes. Most patients can be transitioned through 2 stages of palliation without CPB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Surgery, Rady Children's Hospital + University of California San Diego, 3020 Children's Way, MC5004, San Diego, CA, 92123, USA. sganta@ualberta.ca.
- Pediatrics, Division of Cardiology, University of California San Diego, San Diego, CA, USA.
- Cardiothoracic Surgery, Rady Children's Hospital + University of California San Diego, 3020 Children's Way, MC5004, San Diego, CA, 92123, USA.
- Division of Pediatric Cardiac Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Zitieren
APA
Ganta, S., Haley, J., El-Said, H., Lane, B., Haldeman, S., Karamlou, T., Moore, J., Rao, R., & Nigro, J. J. (2024). Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow. Pediatric Cardiology. https://doi.org/10.1007/s00246-023-03386-5
Vancouver
Ganta S, Haley J, El-Said H, Lane B, Haldeman S, Karamlou T, et al. Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow. Pediatric Cardiology. 2024. doi:10.1007/s00246-023-03386-5
BibTeX
@article{Ganta2024,
author = {Ganta, Srujan and Haley, Jessica and El-Said, Howaida and Lane, Brian and Haldeman, Shylah and Karamlou, Tara and Moore, John and Rao, Rohit and Nigro, John J},
title = {Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow},
journal = {Pediatric Cardiology},
year = {2024},
doi = {10.1007/s00246-023-03386-5}
}
EUVIMED